A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations

Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, Tatsuo Ito, Charlotte K.Y. Ng, Lu Wang, Diana Lim, Angela Marchetti, Agnes Viale, Mono Pirun, Nicholas D. Socci, Li Xuan Qin, Raf Sciot, Julia Bridge, Samuel Singer, Paul Meyers, Leonard H. Wexler, Frederic G. Barr, Snjezana Dogan, Jonathan A. FletcherJorge S. Reis-Filho, Marc Ladanyi

Research output: Contribution to journalArticlepeer-review

81 Citations (Scopus)

Fingerprint Dive into the research topics of 'A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences